FDA approves cellular therapy for patients with Type 1 diabetes
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased
Keeping your diabetes kit safe and in one place.
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased
The FDA has approved the Lantidra allogeneic pancreatic islet cellular therapy developed by CellTrans to treat diabetes. This is the first
Beta Bionics has raised private funding of $100m to support commercialization and further development of iLet Bionic Pancreas, its recently-authorized automated insulin
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems
New data suggests that significant reductions in HbA1c have occurred over time among adults with Type 1 diabetes as their use
The Association of Medical Research Charities (AMRC) is a membership organisation dedicated to supporting medical research charities in saving and improving